Multi-layered cancer chromosomal instability phenotype

Frontiers in Oncology

Volumn 3 DEC, Issue , 2013, Pages

  Roschke, Anna V ^a   Rozenblum, Ester ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Aneuploidy; Cancer; Chromosomal instability; Intra tumor heterogeneity; W CIN

Indexed keywords

ANEUPLOIDY; APOPTOSIS; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL DIVISION; CELL HETEROGENEITY; CELL POPULATION; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; COPY NUMBER VARIATION; HUMAN; M PHASE CELL CYCLE CHECKPOINT; NEOPLASM; NONHUMAN; PHENOTYPE; REVIEW; TUMOR CELL; TUMOR PROMOTION;

EID: 84892404359     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00302     Document Type: Review

References (137)

1. Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol (2006) 18(6):658-67. doi: 10.1016/j.ceb.2006.10.002.
2. Nowell PC. The clonal evolution of tumor cell populations. Science (1976) 194(4260):23-8. doi:10.1126/science.959840.
3. Nicholson JM, Cimini D. Cancer karyotypes: survival of the fittest. Front Oncol (2013) 3:148. doi:10.3389/fonc.2013.00148.
4. Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet (2003) 34(4):369-76. doi:10.1038/ng1215.
5. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet (2006) 38(9):1043-8. doi:10.1038/ng1861.
6. Swanton C, Nicke B, Schuett M, Eklund AC, Ng C, Li Q, et al. Chromosomal instability determines taxane response. Proc Natl Acad Sci U S A (2009) 106(21):8671-6. doi:10.1073/pnas.0811835106.
7. Bakhoum SF, Compton DA. Chromosomal instability and cancer: a complex relationship with therapeutic potential. J Clin Invest (2012) 122(4):1138-43. doi:10.1172/JCI59954.
8. Lee AJ, Endesfelder D, Rowan AJ, Walther A, Birkbak NJ, Futreal PA, et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res (2011) 71(5):1858-70. doi:10.1158/0008-5472.CAN-10-3604.
9. McGranahan N, Burrell RA, Endesfelder D, Novelli MR, Swanton C. Cancer chromosomal instability: therapeutic and diagnostic challenges. EMBO Rep (2012) 13(6):528-38. doi:10.1038/embor.2012.61.
10. Cope L, Wu RC, Shih Ie M, Wang TL. High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome. Gynecol Oncol (2013) 128(3):500-5. doi:10.1016/j.ygyno.2012.11.031.
11. Lagarde P, Perot G, Kauffmann A, Brulard C, Dapremont V, Hostein I, et al. Mitotic checkpoints and chromosome instability are strong predictors of clinical outcome in gastrointestinal stromal tumors. Clin Cancer Res (2012) 18(3):826-38. doi:10.1158/1078-0432.CCR-11-1610.
12. Ried T, Heselmeyer-Haddad K, Blegen H, Schrock E, Auer G. Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer (1999) 25(3):195-204. doi:10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8.
13. Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, et al. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. J Clin Oncol (2012) 30(18):2256-64. doi:10.1200/JCO.2011.38.6490.
14. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res (1997) 57(8):1597-604.
15. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res (1997) 57(13):2765-80.
16. Hyman E, Kauraniemi P, Hautaniemi S, Wolf M, Mousses S, Rozenblum E, et al. Impact of DNA amplification on gene expression patterns in breast cancer. Cancer Res (2002) 62(21):6240-5.
17. Wolf M, Mousses S, Hautaniemi S, Karhu R, Huusko P, Allinen M, et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. Neoplasia (2004) 6(3):240-7. doi:10.1593/neo.03439.
18. Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature (2010) 463(7283):899-905. doi:10.1038/nature08822.
19. Ueno T, Emi M, Sato H, Ito N, Muta M, Kuroi K, et al. Genome-wide copy number analysis in primary breast cancer. Expert Opin Ther Targets (2012) 16(Suppl 1):S31-5. doi:10.1517/14728222.2011.636739.
20. Pikor L, Thu K, Vucic E, Lam W. The detection and implication of genome instability in cancer. Cancer Metastasis Rev (2013) 32(3-4):341-52. doi:10.1007/s10555-013-9429-5.
21. Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, et al. Cancer development, progression, and therapy: an epigenetic overview. Int J Mol Sci (2013) 14(10):21087-113. doi:10.3390/ijms141021087.
22. Network TCGA. Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 487(7407):330-7. doi:10.1038/nature11252.
23. Network TCGAR. Integrated genomic characterization of endometrial carcinoma. Nature (2013) 497(7447):67-73. doi:10.1038/nature12113.
24. Network TCGAR. Integrated genomic analyses of ovarian carcinoma. Nature (2011) 474(7353):609-15. doi:10.1038/nature10166.
25. Hoglund M, Gisselsson D, Sall T, Mitelman F. Coping with complexity. Multivariate analysis of tumor karyotypes. Cancer Genet Cytogenet (2002) 135(2):103-9. doi:10.1016/S0165-4608(01)00645-8.
26. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, et al. Comparative lesion sequencing provides insights into tumor evolution. Proc Natl Acad Sci U S A (2008) 105(11):4283-8. doi:10.1073/pnas.0712345105.
27. Almendro V, Marusyk A, Polyak K. Cellular heterogeneity and molecular evolution in cancer. Annu Rev Pathol (2013) 8:277-302. doi:10.1146/annurev-pathol-020712-163923.
28. Fidler IJ. Tumor heterogeneity and the biology of cancer invasion and metastasis. Cancer Res (1978) 38(9):2651-60.
29. Heim S, Jin Y, Mandahl N, Biorklund A, Wennerberg J, Jonsson N, et al. Multiple unrelated clonal chromosome abnormalities in an in situ squamous cell carcinoma of the skin. Cancer Genet Cytogenet (1988) 36(2):149-53. doi:10.1016/0165-4608(88)90137-9.
30. Gray JW, Collins C, Henderson IC, Isola J, Kallioniemi A, Kallioniemi OP, et al. Molecular cytogenetics of human breast cancer. Cold Spring Harb Symp Quant Biol (1994) 59:645-52. doi:10.1101/SQB.1994.059.01.074.
31. Pandis N, Teixeira MR, Gerdes AM, Limon J, Bardi G, Andersen JA, et al. Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer (1995) 76(2):250-8. doi:10.1002/1097-0142(19950715)76:2<250::AID-CNCR2820760215>3.0.CO;2-W.
32. Aubele M, Mattis A, Zitzelsberger H, Walch A, Kremer M, Hutzler P, et al. Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridization. Cancer Genet Cytogenet (1999) 110(2):94-102. doi:10.1016/S0165-4608(98)00205-2.
33. Steilen-Gimbel H, Henn W, Kolles H, Moringlane JR, Feiden W, Steudel WI, et al. Early proliferation enhancement by monosomy 10 and intratumor heterogeneity in malignant human gliomas as revealed by smear preparations from biopsies. Genes Chromosomes Cancer (1996) 16(3):180-4. doi:10.1002/(SICI)1098-2264(199607)16:3<180::AID-GCC4>3.0.CO;2-V.
34. Orndal C, Rydholm A, Willen H, Mitelman F, Mandahl N. Cytogenetic intratumor heterogeneity in soft tissue tumors. Cancer Genet Cytogenet (1994) 78(2):127-37. doi:10.1016/0165-4608(94)90080-9.
35. Gorunova L, Hoglund M, Andren-Sandberg A, Dawiskiba S, Jin Y, Mitelman F, et al. Cytogenetic analysis of pancreatic carcinomas: intratumor heterogeneity and nonrandom pattern of chromosome aberrations. Genes Chromosomes Cancer (1998) 23(2):81-99. doi:10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0.
36. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature (2011) 472(7341):90-4. doi:10.1038/nature09807.
37. Xu X, Hou Y, Yin X, Bao L, Tang A, Song L, et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell (2012) 148(5):886-95. doi:10.1016/j.cell.2012.02.025.
38. Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell (2012) 148(5):873-85. doi:10.1016/j.cell.2012.02.028.
39. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell (2011) 144(1):27-40. doi:10.1016/j.cell.2010.11.055.
40. Al-Mulla F, Keith WN, Pickford IR, Going JJ, Birnie GD. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer (1999) 24(4):306-14. doi:10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5.
41. Magrangeas F, Avet-Loiseau H, Gouraud W, Lode L, Decaux O, Godmer P, et al. Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia (2013) 27(2):473-81. doi:10.1038/leu.2012.226.
42. Swanton C, Caldas C. Molecular classification of solid tumours: towards pathway-driven therapeutics. Br J Cancer (2009) 100(10):1517-22. doi:10.1038/sj.bjc.6605031.
43. Logothetis CJ. Re: intratumor heterogeneity and branched evolution revealed by multiregion sequencing. Eur Urol (2013) 64(1):170. doi:10.1016/j.eururo.2013.04.025.
44. Roschke AV, Tonon G, Gehlhaus KS, McTyre N, Bussey KJ, Lababidi S, et al. Karyotypic complexity of the NCI-60 drug-screening panel. Cancer Res (2003) 63(24):8634-47.
45. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature (1997) 386(6625):623-7. doi:10.1038/386623a0.
46. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature (1998) 396(6712):643-9. doi:10.1038/25292.
47. Geigl JB, Obenauf AC, Schwarzbraun T, Speicher MR. Defining 'chromosomal instability'. Trends Genet (2008) 24(2):64-9. doi:10.1016/j.tig.2007.11.006.
48. Thompson SL, Compton DA. Examining the link between chromosomal instability and aneuploidy in human cells. J Cell Biol (2008) 180(4):665-72. doi:10.1083/jcb.200712029.
49. Roschke AV, Stover K, Tonon G, Schaffer AA, Kirsch IR. Stable karyotypes in epithelial cancer cell lines despite high rates of ongoing structural and numerical chromosomal instability. Neoplasia (2002) 4(1):19-31. doi:10.1038/sj.neo.7900197.
50. Cimini D, Howell B, Maddox P, Khodjakov A, Degrassi F, Salmon ED. Merotelic kinetochore orientation is a major mechanism of aneuploidy in mitotic mammalian tissue cells. J Cell Biol (2001) 153(3):517-27. doi:10.1083/jcb.153.3.517.
51. Thompson SL, Compton DA. Chromosome missegregation in human cells arises through specific types of kinetochore-microtubule attachment errors. Proc Natl Acad Sci U S A (2011) 108(44):17974-8. doi:10.1073/pnas.1109720108.
52. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature (2009) 460(7252):278-82. doi:10.1038/nature08136.
53. Silkworth WT, Nardi IK, Scholl LM, Cimini D. Multipolar spindle pole coalescence is a major source of kinetochore mis-attachment and chromosome mis-segregation in cancer cells. PLoS One (2009) 4(8):e6564. doi:10.1371/journal.pone.0006564.
54. Thompson SL, Compton DA. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol (2010) 188(3):369-81. doi:10.1083/jcb.200905057.
55. Nicholson JM, Cimini D. How mitotic errors contribute to karyotypic diversity in cancer. Adv Cancer Res (2011) 112:43-75. doi:10.1016/B978-0-12-387688-1.00003-X.
56. Schvartzman JM, Duijf PH, Sotillo R, Coker C, Benezra R. Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell (2011) 19(6):701-14. doi:10.1016/j.ccr.2011.04.017.
57. Hood EA, Kettenbach AN, Gerber SA, Compton DA. Plk1 regulates the kinesin-13 protein Kif2b to promote faithful chromosome segregation. Mol Biol Cell (2012) 23(12):2264-74. doi:10.1091/mbc.E11-12-1013.
58. Kabeche L, Compton DA. Checkpoint-independent stabilization of kinetochore-microtubule attachments by Mad2 in human cells. Curr Biol (2012) 22(7):638-44. doi:10.1016/j.cub.2012.02.030.
59. Vitre BD, Cleveland DW. Centrosomes, chromosome instability (CIN) and aneuploidy. Curr Opin Cell Biol (2012) 24(6):809-15. doi:10.1016/j.ceb.2012.10.006.
60. Saunders WS, Shuster M, Huang X, Gharaibeh B, Enyenihi AH, Petersen I, et al. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc Natl Acad Sci U S A (2000) 97(1):303-8. doi:10.1073/pnas.97.1.303.
61. Network TCGAR. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 455(7216):1061-8. doi:10.1038/nature07385.
62. Orr B, Compton DA. A double-edged sword: how oncogenes and tumor suppressor genes can contribute to chromosomal instability. Front Oncol (2013) 3:164. doi:10.3389/fonc.2013.00164.
63. Barber TD, McManus K, Yuen KW, Reis M, Parmigiani G, Shen D, et al. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers. Proc Natl Acad Sci U S A (2008) 105(9):3443-8. doi:10.1073/pnas.0712384105.
64. Wang X, Cheung HW, Chun AC, Jin DY, Wong YC. Mitotic checkpoint defects in human cancers and their implications to chemotherapy. Front Biosci (2008) 13:2103-14. doi:10.2741/2827.
65. Foijer F, Draviam VM, Sorger PK. Studying chromosome instability in the mouse. Biochim Biophys Acta (2008) 1786(1):73-82. doi:10.1016/j.bbcan.2008.07.004.
66. Rao CV, Yamada HY, Yao Y, Dai W. Enhanced genomic instabilities caused by deregulated microtubule dynamics and chromosome segregation: a perspective from genetic studies in mice. Carcinogenesis (2009) 30(9):1469-74. doi:10.1093/carcin/bgp081.
67. Weaver BA, Cleveland DW. The role of aneuploidy in promoting and suppressing tumors. J Cell Biol (2009) 185(6):935-7. doi:10.1083/jcb.200905098.
68. Michel LS, Liberal V, Chatterjee A, Kirchwegger R, Pasche B, Gerald W, et al. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature (2001) 409(6818):355-9. doi:10.1038/35053094.
69. Dai W, Wang Q, Liu T, Swamy M, Fang Y, Xie S, et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res (2004) 64(2):440-5. doi:10.1158/0008-5472.CAN-03-3119.
70. Hanks S, Coleman K, Reid S, Plaja A, Firth H, Fitzpatrick D, et al. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat Genet (2004) 36(11):1159-61. doi:10.1038/ng1449.
71. Jeganathan KB, Baker DJ, van Deursen JM. Securin associates with APCCdh1 in prometaphase but its destruction is delayed by Rae1 and Nup98 until the metaphase/anaphase transition. Cell Cycle (2006) 5(4):366-70. doi:10.4161/cc.5.4.2483.
72. Babu JR, Jeganathan KB, Baker DJ, Wu X, Kang-Decker N, van Deursen JM. Rae1 is an essential mitotic checkpoint regulator that cooperates with Bub3 to prevent chromosome missegregation. J Cell Biol (2003) 160(3):341-53. doi:10.1083/jcb.200211048.
73. Baker DJ, Jeganathan KB, Cameron JD, Thompson M, Juneja S, Kopecka A, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet (2004) 36(7):744-9. doi:10.1038/ng1382.
74. Cimini D. Merotelic kinetochore orientation, aneuploidy, and cancer. Biochim Biophys Acta (2008) 1786(1):32-40. doi:10.1016/j.bbcan.2008.05.003.
75. Bakhoum SF, Thompson SL, Manning AL, Compton DA. Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol (2009) 11(1):27-35. doi:10.1038/ncb1809.
76. Bakhoum SF, Genovese G, Compton DA. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol (2009) 19(22):1937-42. doi:10.1016/j.cub.2009.09.055.
77. Bakhoum SF, Compton DA. Cancer: CINful centrosomes. Curr Biol (2009) 19(15):R642-5. doi:10.1016/j.cub.2009.06.039.
78. Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer (2002) 2(11):815-25. doi:10.1038/nrc924.
79. Brinkley BR. Managing the centrosome numbers game: from chaos to stability in cancer cell division. Trends Cell Biol (2001) 11(1):18-21. doi:10.1016/S0962-8924(00)01872-9.
80. Ring D, Hubble R, Kirschner M. Mitosis in a cell with multiple centrioles. J Cell Biol (1982) 94(3):549-56. doi:10.1083/jcb.94.3.549.
81. Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, et al. Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations. Genes Chromosomes Cancer (2000) 27(2):183-90. doi:10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P.
82. Ng TM, Waples WG, Lavoie BD, Biggins S. Pericentromeric sister chromatid cohesion promotes kinetochore biorientation. Mol Biol Cell (2009) 20(17):3818-27. doi:10.1091/mbc.E09-04-0330.
83. Yu R, Lu W, Chen J, McCabe CJ, Melmed S. Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology (2003) 144(11):4991-8. doi:10.1210/en.2003-0305.
84. Zhang N, Ge G, Meyer R, Sethi S, Basu D, Pradhan S, et al. Overexpression of separase induces aneuploidy and mammary tumorigenesis. Proc Natl Acad Sci U S A (2008) 105(35):13033-8. doi:10.1073/pnas.0801610105.
85. Malumbres M. Oncogene-induced mitotic stress: p53 and pRb get mad too. Cancer Cell (2011) 19(6):691-2. doi:10.1016/j.ccr.2011.05.023.
86. Coschi CH, Dick FA. Chromosome instability and deregulated proliferation: an unavoidable duo. Cell Mol Life Sci (2012) 69(12):2009-24. doi:10.1007/s00018-011-0910-4.
87. Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, et al. Replication stress links structural and numerical cancer chromosomal instability. Nature (2013) 494(7438):492-6. doi:10.1038/nature11935.
88. Dereli-Oz A, Versini G, Halazonetis TD. Studies of genomic copy number changes in human cancers reveal signatures of DNA replication stress. Mol Oncol (2011) 5(4):308-14. doi:10.1016/j.molonc.2011.05.002.
89. Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev (2007) 17(2):157-62. doi:10.1016/j.gde.2007.02.011.
90. Gao C, Furge K, Koeman J, Dykema K, Su Y, Cutler ML, et al. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc Natl Acad Sci U S A (2007) 104(21):8995-9000. doi:10.1073/pnas.0700631104.
91. Torres EM, Williams BR, Amon A. Aneuploidy: cells losing their balance. Genetics (2008) 179(2):737-46. doi:10.1534/genetics.108.090878.
92. Torres EM, Sokolsky T, Tucker CM, Chan LY, Boselli M, Dunham MJ, et al. Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science (2007) 317(5840):916-24. doi:10.1126/science.1142210.
93. Hoffelder DR, Luo L, Burke NA, Watkins SC, Gollin SM, Saunders WS. Resolution of anaphase bridges in cancer cells. Chromosoma (2004) 112(8):389-97. doi:10.1007/s00412-004-0284-6.
94. Janssen A, van der Burg M, Szuhai K, Kops GJ, Medema RH. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science (2011) 333(6051):1895-8. doi:10.1126/science.1210214.
95. Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature (2012) 482(7383):53-8. doi:10.1038/nature10802.
96. Duesberg P, Rasnick D, Li R, Winters L, Rausch C, Hehlmann R. How aneuploidy may cause cancer and genetic instability. Anticancer Res (1999) 19(6A):4887-906.
97. Sheltzer JM, Amon A. The aneuploidy paradox: costs and benefits of an incorrect karyotype. Trends Genet (2011) 27(11):446-53. doi:10.1016/j.tig.2011.07.003.
98. Tang YC, Amon A. Gene copy-number alterations: a cost-benefit analysis. Cell (2013) 152(3):394-405. doi:10.1016/j.cell.2012.11.043.
99. Tang YC, Williams BR, Siegel JJ, Amon A. Identification of aneuploidy-selective antiproliferation compounds. Cell (2011) 144(4):499-512. doi:10.1016/j.cell.2011.01.017.
100. Stingele S, Stoehr G, Peplowska K, Cox J, Mann M, Storchova Z. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol Syst Biol (2012) 8:608. doi:10.1038/msb.2012.40.
101. Sheltzer JM, Torres EM, Dunham MJ, Amon A. Transcriptional consequences of aneuploidy. Proc Natl Acad Sci U S A (2012) 109(31):12644-9. doi:10.1073/pnas.1209227109.
102. Upender MB, Habermann JK, McShane LM, Korn EL, Barrett JC, Difilippantonio MJ, et al. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res (2004) 64(19):6941-9. doi:10.1158/0008-5472.CAN-04-0474.
103. Williams BR, Prabhu VR, Hunter KE, Glazier CM, Whittaker CA, Housman DE, et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science (2008) 322(5902):703-9. doi:10.1126/science.1160058.
104. Pavelka N, Rancati G, Zhu J, Bradford WD, Saraf A, Florens L, et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature (2010) 468(7321):321-5. doi:10.1038/nature09529.
105. elBaradi TT, van der Sande CA, Mager WH, Raue HA, Planta RJ. The cellular level of yeast ribosomal protein L25 is controlled principally by rapid degradation of excess protein. Curr Genet (1986) 10(10):733-9. doi:10.1007/BF00405095.
106. Williams BR, Amon A. Aneuploidy: cancer's fatal flaw? Cancer Res (2009) 69(13):5289-91. doi:10.1158/0008-5472.CAN-09-0944.
107. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z, et al. The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci U S A (2010) 107(32):14188-93. doi:10.1073/pnas.1005960107.
108. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science (2013) 339(6127):1546-58. doi:10.1126/science.1235122.
109. Bunz F, Fauth C, Speicher MR, Dutriaux A, Sedivy JM, Kinzler KW, et al. Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res (2002) 62(4):1129-33.
110. Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet (2012) 13(3):189-203. doi:10.1038/nrg3123.
111. Storchova Z, Breneman A, Cande J, Dunn J, Burbank K, O'Toole E, et al. Genome-wide genetic analysis of polyploidy in yeast. Nature (2006) 443(7111):541-7. doi:10.1038/nature05178.
112. Torres EM, Dephoure N, Panneerselvam A, Tucker CM, Whittaker CA, Gygi SP, et al. Identification of aneuploidy-tolerating mutations. Cell (2010) 143(1):71-83. doi:10.1016/j.cell.2010.08.038.
113. Sheltzer JM, Blank HM, Pfau SJ, Tange Y, George BM, Humpton TJ, et al. Aneuploidy drives genomic instability in yeast. Science (2011) 333(6045):1026-30. doi:10.1126/science.1206412.
114. Duijf PH, Benezra R. The cancer biology of whole-chromosome instability. Oncogene (2013) 32(40):4727-36. doi:10.1038/onc.2012.616.
115. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell (2010) 140(6):883-99. doi:10.1016/j.cell.2010.01.025.
116. Roschke AV, Kirsch IR. Targeting karyotypic complexity and chromosomal instability of cancer cells. Curr Drug Targets (2010) 11(10):1341-50. doi:10.2174/1389450111007011341.
117. Potapova TA, Zhu J, Li R. Aneuploidy and chromosomal instability: a vicious cycle driving cellular evolution and cancer genome chaos. Cancer Metastasis Rev (2013) 32(3-4):377-89. doi:10.1007/s10555-013-9436-6.
118. Schvartzman JM, Sotillo R, Benezra R. Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer (2010) 10(2):102-15. doi:10.1038/nrc2781.
119. Siegel JJ, Amon A. New insights into the troubles of aneuploidy. Annu Rev Cell Dev Biol (2012) 28:189-214. doi:10.1146/annurev-cellbio-101011-155807.
120. Ganmore I, Smooha G, Izraeli S. Constitutional aneuploidy and cancer predisposition. Hum Mol Genet (2009) 18(R1):R84-93. doi:10.1093/hmg/ddp084.
121. Pfau SJ, Amon A. Chromosomal instability and aneuploidy in cancer: from yeast to man. EMBO Rep (2012) 13(6):515-27. doi:10.1038/embor.2012.65.
122. Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA. Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study. Lancet Oncol (2008) 9(3):239-46. doi:10.1016/S1470-2045(08)70033-0.
123. Reish O, Regev M, Kanesky A, Girafi S, Mashevich M. Sporadic aneuploidy in PHA-stimulated lymphocytes of trisomies 21, 18, and 13. Cytogenet Genome Res (2011) 133(2-4):184-9. doi:10.1159/000323504.
124. Roschke AV, Glebov OK, Lababidi S, Gehlhaus KS, Weinstein JN, Kirsch IR. Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance. Neoplasia (2008) 10(11):1222-30.
125. Markert EK, Levine AJ, Vazquez A. Proliferation and tissue remodeling in cancer: the hallmarks revisited. Cell Death Dis (2012) 3:e397. doi:10.1038/cddis.2012.140.
126. McClelland SE, Burrell RA, Swanton C. Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy. Cell Cycle (2009) 8(20):3262-6. doi:10.4161/cc.8.20.9690.
127. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumours. Trends Cell Biol (1999) 9(12):M57-60. doi:10.1016/S0962-8924(99)01661-X.
128. Pavelka N, Rancati G, Li R. Dr. Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr Opin Cell Biol (2010) 22(6):809-15. doi:10.1016/j.ceb.2010.06.003.
129. Schafer M, Werner S. Cancer as an overhealing wound: an old hypothesis revisited. Nat Rev Mol Cell Biol (2008) 9(8):628-38. doi:10.1038/nrm2455.
130. Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis (2009) 30(7):1073-81. doi:10.1093/carcin/bgp127.
131. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M, et al. Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev (2008) 22(16):2189-203. doi:10.1101/gad.1700908.
132. Rebacz B, Larsen TO, Clausen MH, Ronnest MH, Loffler H, Ho AD, et al. Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen. Cancer Res (2007) 67(13):6342-50. doi:10.1158/0008-5472.CAN-07-0663.
133. Ronnest MH, Rebacz B, Markworth L, Terp AH, Larsen TO, Kramer A, et al. Synthesis and structure-activity relationship of griseofulvin analogues as inhibitors of centrosomal clustering in cancer cells. J Med Chem (2009) 52(10):3342-7. doi:10.1021/jm801517j.
134. Roschke AV, Lababidi S, Tonon G, Gehlhaus KS, Bussey K, Weinstein JN, et al. Karyotypic "state" as a potential determinant for anticancer drug discovery. Proc Natl Acad Sci U S A (2005) 102(8):2964-9. doi:10.1073/pnas.0405578102.
135. Roschke AV, Kirsch IR. Targeting cancer cells by exploiting karyotypic complexity and chromosomal instability. Cell Cycle (2005) 4(5):679-82. doi:10.4161/cc.4.5.1687.
136. Wallqvist A, Huang R, Covell DG, Roschke AV, Gelhaus KS, Kirsch IR. Drugs aimed at targeting characteristic karyotypic phenotypes of cancer cells. Mol Cancer Ther (2005) 4(10):1559-68. doi:10.1158/1535-7163.MCT-05-0224.
137. Burrell RA, Juul N, Johnston SR, Reis-Filho JS, Szallasi Z, Swanton C. Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer. J Cell Biochem (2010) 111(4):782-90. doi:10.1002/jcb.22781.